Catalyst Pharmaceutical CPRX Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 86%+0.8pp | 85.2%-0.5pp | 85.7%-0.1pp | 85.8%-0.3pp | 86.1%+0.1pp | |
| Operating margin | 44.8%+1.1pp | 43.8%-1.0pp | 44.8%+1.2pp | 43.6%+0.3pp | 43.3%+3.6pp | |
| Net margin | 37.1%+0.7pp | 36.4%-1.2pp | 37.6%+0.3pp | 37.4%+0.4pp | 36.9%+3.6pp | |
| Returns | ||||||
| Return on equity | 24.5%-1.0pp | 25.5%-2.0pp | 27.5%-1.0pp | 28.5%-0.6pp | 29.1%-0.3pp | |
| Return on invested capital | 83.9%-0.6pp | 84.5%-2.1pp | 86.6%+2.2pp | 84.4%+9.4pp | 75%+11.7pp | |
| Efficiency | ||||||
| Asset turnover | 0.6×0.0× | 0.6×0.0× | 0.6×0.0× | 0.7×0.0× | 0.7×-0.1× | |
| Liquidity | ||||||
| Current ratio | 7.1×+1.0× | 6.1×-0.5× | 6.6×-0.1× | 6.7×+0.6× | 6.1×+1.0× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Net debt / EBITDA | -2.5×-0.1× | -2.4×-0.1× | -2.3×0.0× | -2.3×-0.2× | -2.1×+0.1× | |
| Per Share | ||||||
| Book value per share | $7.98+6.4% | $7.50+3.6% | $7.24+7.9% | $6.71+7.3% | $6.26+7.4% | |
| Valuation | ||||||
| Market capitalization | $3.02B+5.4% | $2.87B+19.0% | $2.41B-10.4% | $2.69B-8.6% | $2.95B+18.3% | |
| Price / earnings | 13.7×+0.3× | 13.4×+2.3× | 11.1×-1.8× | 12.9×-2.0× | 14.9×-0.3× | |
| Price / sales | 5.1×+0.2× | 4.9×+0.7× | 4.2×-0.7× | 4.8×-0.7× | 5.5×+0.4× | |
| Price / book | 3×0.0× | 3×+0.4× | 2.6×-0.5× | 3.1×-0.6× | 3.7×+0.3× | |
| EV / EBITDA | 7.4×+0.1× | 7.3×+1.5× | 5.8×-1.4× | 7.3×-1.5× | 8.8×+0.3× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Catalyst Pharmaceutical's profit margins?
- Catalyst Pharmaceutical (CPRX) runs a 86.0% gross margin and a 44.8% operating margin, with a 37.1% net margin.
- Where do Catalyst Pharmaceutical's ratios come from?
- Every ratio is computed from Catalyst Pharmaceutical's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.